Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.300
+0.012 (4.17%)
At close: Mar 6, 2026, 4:00 PM EST
0.302
+0.002 (0.60%)
After-hours: Mar 6, 2026, 7:45 PM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $27.35 million as of March 6, 2026. Its market cap has decreased by -68.49% in one year.
Market Cap
27.35M
Enterprise Value
13.11M
1-Year Change
-68.49%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $27.35M, a decrease of -85.86%. That is a compound annual growth rate of -21.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 23.60M | -1.67% |
| Dec 31, 2025 | 24.00M | -65.27% |
| Dec 31, 2024 | 69.10M | -41.98% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dyadic International | 28.13M |
| Kyntra Bio | 27.85M |
| IGC Pharma | 27.31M |
| AEON Biopharma | 26.06M |
| Hyperion DeFi | 26.03M |
| Passage Bio | 25.81M |
| Exicure | 25.43M |
| Boundless Bio | 25.07M |